The safety profile of cagrilintide, as observed in clinical trials , is primarily characterized by gastrointestinal disturbances , most notably mild to moderate nausea during the initial titration phase
Hutchinson explained that muciniphila translates to mucin lover. One of Akkermansias superpowers is its ability to stimulate increased mucin production in the gut lining, which strengthens gut barrier function based on preclinical studies. In fact, research has shown that low levels of Akkermansia are correlated with an increase in health outcomes, which makes it all the more wild that most of us havent heard of it until Pendulum brought it to our attention
References: [1] The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease [2] [3] Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial [4] STEP-HFpEF: Semaglutide Improves Symptoms, Physical Limitations, Weight Loss in Patients With HFpEF and Obesity
A 2016 review by Indian dermatologists recommends against IV glutathione injections for skin lightening until better safety data exists
Can I drink alcohol while on Wegovy